A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer
Nanoscale · 2025
DOI: 10.1039/d4nr03471f ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Siyu Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig-Maximilians-University, Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Butenandtstraße 5-13, Munich, 81377, Germany. …. Hauptthemen laut MEDLINE: Lung Neoplasms, Micelles, Proto-Oncogene Proteins p21(ras), CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: China Scholarship Council, Alexander von Humboldt-Stiftung, H2020 European Research Council.
Abstract (Originalsprache)
CRISPR-Cas9 has emerged as a highly effective and customizable genome editing tool, holding significant promise for the treatment of KRAS mutations in lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ludwig-Maximilians-University, Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Butenandtstraße 5-13, Munich, 81377, Germany. siyu.chen@cup.uni-muenchen.de.
Förderung
- China Scholarship Council
- Alexander von Humboldt-Stiftung
- H2020 European Research Council
Zitieren
APA
Chen, S., Triki, M., Pinto Carneiro, S., & Merkel, O. M. (2025). A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer. Nanoscale. https://doi.org/10.1039/d4nr03471f
Vancouver
Chen S, Triki M, Pinto Carneiro S, Merkel OM. A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer. Nanoscale. 2025. doi:10.1039/d4nr03471f
BibTeX
@article{Chen2025,
author = {Chen, Siyu and Triki, Mariem and Pinto Carneiro, Simone and Merkel, Olivia Monika},
title = {A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr03471f}
}
EUVIMED